Cargando…
Efficacy of DA-9701 (Motilitone) in Functional Dyspepsia Compared to Pantoprazole: A Multicenter, Randomized, Double-blind, Non-inferiority Study
BACKGROUND/AIMS: The effect of proton pump inhibitors (PPI) in Asian functional dyspepsia (FD) patients has not been well established as in Western countries. DA-9701, a novel prokinetic agent, stimulates gastric emptying and modulates visceral hypersensitivity in vivo and in human studies. This stu...
Autores principales: | Jung, Hye-Kyung, Lee, Kwang Jae, Choi, Myung-Gyu, Park, Hyojin, Lee, Joon Seong, Rhee, Poong-Lyul, Kim, Nayoung, Park, Kyung Sik, Choi, Suck Chei, Lee, Oh Young, Huh, Kyu Chan, Song, Geun Am, Hong, Su Jin, Sohn, Chong Il, Jung, Hwoon-Yong, Lee, Yong Chan, Rew, Jong Sun, Jee, Sam Ryong, Kwon, Joong Goo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Neurogastroenterology and Motility
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819864/ https://www.ncbi.nlm.nih.gov/pubmed/26811504 http://dx.doi.org/10.5056/jnm15178 |
Ejemplares similares
-
Randomized, Controlled, Multi-center Trial: Comparing the Safety and Efficacy of DA-9701 and Itopride Hydrochloride in Patients With Functional Dyspepsia
por: Choi, Myung-Gyu, et al.
Publicado: (2015) -
DA-9701 (Motilitone): A Multi-Targeting Botanical Drug for the Treatment of Functional Dyspepsia
por: Jin, Mirim, et al.
Publicado: (2018) -
A Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of DA-9701 (Motilitone) in Patients With Constipation-type Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Pilot Study
por: Lee, Ju Yup, et al.
Publicado: (2022) -
Efficacy and Safety of DWJ1252 Compared With Gasmotin in the Treatment of Functional Dyspepsia: A Multicenter, Randomized, Double-blind, Active-controlled Study
por: Park, Jin Hwa, et al.
Publicado: (2021) -
Efficacy and Safety of Tiropramide in the Treatment of Patients With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-blind, Non-inferiority Trial, Compared With Octylonium
por: Lee, Kang Nyeong, et al.
Publicado: (2014)